News
AbbVie has claimed FDA approval for Emblaveo, a new antibiotic product to treat complicated intra-abdominal infections (cIAI), including those caused by Gram-negative bacteria that represent a ...
The CHMP also backed approval of Pfizer’s antibiotic infusion Emblaveo (aztreonam-avibactam) to treat complicated intra-abdominal infection (cIAI) and complicated urinary tract infection (cUTI ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback